Spring direct naar de hoofdnavigatie of de inhoud

Sjoerd Postma

Patent attorney

‘Having ideas worthy of protection is not restricted to big companies or geniuses like Einstein. Anyone can be an inventor!’
Sjoerd Postma

Sjoerd Postma

  • Life Sciences
  • Trainee Patent Attorney

Sjoerd Postma studied Molecular Life Sciences at Radboud University Nijmegen. His research internships concerned click chemistry, enzyme-loaded nanoparticles, and the development of a fluorescent hydrogel to study reaction-diffusion of calcium ions. Sjoerd’s final internship was part of a program of the Radboud Honours Academy. This internship was carried out at the University of Cambridge and its main objective was to measure the conformational dynamics of diubiquitin chains with single-molecule fluorescence techniques.

Continue reading

After obtaining his MSc degree, Sjoerd started a PhD project at Radboud University Nijmegen. His research focused on designing chemical reaction networks in microreactors and hydrogels to better understand the chemistry within living cells.

Education

  • PhD in Physical Organic Chemistry, Radboud University Nijmegen (2017)
  • MSc in Molecular Life Sciences, Radboud University Nijmegen (2013)

Publications

  • S.G.J. Postma, D. te Brinke, i.N. Vialshin, A.S.Y. Wong, W.T.S. Huck, Tetrahedron, 2017, 73, 4896-4900.
  • S.G.J. Postma, I.N. Vialshin, C.Y. Gerritsen, M. Bao, W.T.S. Huck, Angew. Chem. Int. Ed., 2017, 56, 1794-1798.
  • A.S.Y. Wong, S.G.J. Postma, I.N. Vialshin, S.N. Semenov, W.T.S. Huck, J. Am. Chem. Soc., 2015, 137, 12415-12420.
  • S.N. Semenov, A.S.Y. Wong, R.M. van der Made, S.G.J. Postma, J. Groen, H.W.H. van Roekel, T.F.A. de Greef, W.T.S. Huck, Nature Chem., 2015, 7, 160-165.
  • S.N. Semenov, S.G.J. Postma, I.N. Vialshin, W.T.S. Huck, Chem. Comm., 2014, 50, 3089-3092.

Languages

  • Dutch
  • English (fluent)
  • German (basic)
  • French (basic)

Also see these experts

Frits Schut

Frits Schut

  • European Patent Attorney
  • Dutch Patent Attorney
  • Partner
Frits Michiels

Frits Michiels

  • European Patent Attorney
  • Dutch Patent Attorney
  • Senior Associate
More experts

News

The best-known medicine in the world: Aspirin

At the end of the 19th century, a young researcher from Bayer made one the most significant discoveries ever – the painkiller Aspirin. It was valuable for his employer, and also for his father who suffered from rheumatism. It led to a worldwide success!Continue reading

Potentially new opportunities for patents in the United States

In the USA, one of the requirements against which the conclusions of a patent application can be tested is whether it contains a matter that is eligible for patenting.Continue reading

New on Kluwer Patent Blog: Eli Lilly and Company vs. Fresenius Kabi Nederland B.V., Netherlands

By Bart van Wezenbeek. The scope of a patent is to be interpreted according to Art. 69 EPC and the Protocol. If the literal text is limiting, the question is how the skilled person would understand this limitation.Continue reading

Events

European Patent Seminar

Hotel Excelsior München, Schützenstraße, Munich, Germany

Know the latest ins-and-outs concerning examination, opposition and appeal proceedings before the EPO. Be updated on the unitary patent and the unified patent court. Continue reading

Improve your practical knowledge at the IP Academy – Basic

Winthontlaan 6, 3526 KV Utrecht, Utrecht, Netherlands

Follow the annual course on patents, trademarks and designs. For innovative entrepreneurs who wish to improve their intellectual property (IP) know-how, V.O. Patents & Trademarks organizes a basic course on IP on Thursday 26 September. Continue reading

IPBC Asia 2019

Palace Hotel Tokyo, 1 Chome-1-1 Marunouchi, Chiyoda City, Tokyo, Japan

Returning to Tokyo, IPBC Asia 2019 is set to be the largest yet – building on the phenomenal success of the event since its launch in 2013. IPBC Asia is focused on chief IP officers, heads of intellectual property or their equivalents at major corporates from across Asia-Pacific; and their counterparts at major multinationals Continue reading